Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Franklin Income Fund Class A (FKINX)

Net Asset Value
1 Day
Overall Morningstar Rating
Conservative allocation
Style or Category
Sales Expenses
Expense Ratio
Morningstar Risk Rating™
Investment Objective The investment seeks to maximize income while maintaining prospects for capital appreciation. The fund invests in a diversified portfolio of debt and equity securities. The equity securities in which the fund invests consist primarily of common stocks. Debt securities include all varieties of fixed, floating and variable rate instruments, including secured and unsecured bonds, bonds convertible into common stock, senior floating rate and term loans, mortgage-backed securities and other asset-backed securities, debentures, and shorter term instruments. It may invest up to 100% of its total assets in debt securities that are rated below investment grade.


1 month-1.81% 3 years+5.22%
3 months+0.94% 5 years+6.39%
1 year-7.48% Since inception+10.26%
Data through --

Peer Comparisonvs. Conservative allocation

Performance 5-yr return+6.39%+4.85%
Expense ratio0.61%1.21%
Risk 5 year sharpe ratio0.760.90
Net assets$83.0B$1.4B
Average market cap$65.6B$41.7B
Average P/E16.818.2
Portfolio turnover36%36%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyFranklin Templeton Investments
Fund manager & tenureEdward Perks / 13 Years
Minimal initial investment$1,000.00
Minimum IRA investment$250.00


U.S. stock44.75%
Fixed income34.76%
International stock15.02%
Top 5 Sectors
Portfolio weighting
Utilities 33.28%
Healthcare 17.26%
Energy 16.40%
Financial service 14.79%
Telecommunication 9.61%
Top 10 Holdings
Portfolio weighting
RDSA Royal Dutch Shell2.40%
GE General Electric2.17%
PCG PG&E1.67%
DOW Dow Chemical1.45%
CVX Chevron1.40%
SO Southern Co1.27%
PFE Pfizer1.19%
VZ Verizon1.10%
TGT Target1.07%
JNJ Johnson & Johnson1.06%